Home Crystal structure of N-(benzo[d]thiazol-2-yl)-2-chloroacetamide, C9H7ClN2OS
Article Open Access

Crystal structure of N-(benzo[d]thiazol-2-yl)-2-chloroacetamide, C9H7ClN2OS

  • Yi-Ding Geng ORCID logo , Ming-Yu Huang , Yi-Xiu Zhang , Yi-Xia Gong ORCID logo EMAIL logo and Ya-Lu Zhang
Published/Copyright: April 30, 2024

Abstract

C9H7ClN2OS, monoclinic, P21/n (no. 14), a = 8.3507(3) Å, b = 12.3768(4) Å, c = 10.2340(4) Å, β = 96.857(4)°, V = 1050.17(7) Å3, Z = 4, Rgt (F) = 0.0673, wRref (F 2) = 0.2013, T = 296(2) K.

CCDC no.: 2298301

The crystal structure is shown in the figure above. Tables 12 contain details of the measurement method and a list of atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colourless block
Size: 0.12 × 0.11 × 0.10 mm
Wavelength:

μ:
Cu Kα radiation (1.54184 Å)

4.94 mm−1
Diffractometer, scan mode:

θ max, completeness:
New Gemini, ω

72.1°, >99 %
N(hkl)measured, N(hkl)unique, R int: 3775, 2021, 0.063
Criterion for I obs, N(hkl)gt: I obs > 2σ(I obs), 1734
N(param)refined: 144
Programs: SHELX 1 , 3 , Olex2 2
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
C1 0.31615 (14) 0.93636 (7) 0.54550 (10) 0.0520 (4)
S1 0.55038 (9) 0.53525 (6) 0.73413 (7) 0.0265 (3)
O1 0.4705 (3) 0.74346 (19) 0.6681 (2) 0.0338 (6)
N1 0.3053 (3) 0.6184 (2) 0.5616 (2) 0.0222 (6)
N2 0.3123 (3) 0.4335 (2) 0.5997 (2) 0.0227 (6)
C00A 0.2488 (4) 0.8039 (2) 0.5109 (3) 0.0281 (7)
H00A 0.138843 0.796718 0.531461 0.034*
H00B 0.248728 0.789664 0.417658 0.034*
C1 0.3752 (4) 0.5285 (2) 0.6236 (3) 0.0200 (6)
C2 0.4064 (4) 0.3556 (2) 0.6712 (3) 0.0221 (6)
C3 0.3761 (4) 0.2443 (3) 0.6676 (3) 0.0289 (7)
H3 0.287502 0.216333 0.614633 0.035*
C4 0.4802 (4) 0.1769 (3) 0.7442 (3) 0.0326 (8)
H4 0.459930 0.103026 0.743973 0.039*
C5 0.6156 (4) 0.2176 (3) 0.8221 (3) 0.0332 (8)
H5 0.684539 0.170482 0.872398 0.040*
C6 0.6483 (4) 0.3276 (3) 0.8252 (3) 0.0305 (7)
H6 0.738299 0.354831 0.877074 0.037*
C007 0.3539 (4) 0.7216 (2) 0.5888 (3) 0.0217 (6)
C7 0.5426 (3) 0.3963 (3) 0.7485 (3) 0.0226 (6)
O2 0.0328 (3) 0.5976 (2) 0.3794 (3) 0.0422 (7)
H2A −0.063869 0.592092 0.396973 0.063*
H2B 0.034887 0.636194 0.310951 0.063*
H1 0.223 (5) 0.604 (3) 0.514 (4) 0.021 (9)*

1 Source of material

1.0 g(6.66 mmol) 2-aminobenzothiazole, 1.06 ml (13.32 mmol) chloroacetyl chloride and 20 ml tetrahydrofuran were added to a 250 ml round flask and stirred to dissolve, stirred at room temperature for 2 h. After the reaction was completed, poured the reaction liquid into a 500 ml beaker, added an appropriate amount of distilled water, precipitate the solid, and then filter the solid after precipitation. By recrystallization of anhydrous ethanol gave the white solid (1.31 g, 86.8 %). 1H NMR (600 MHz, CDCl3) d 7.82 (s, 1H), 7.48 (s, 1H), 7.84 (s, 1H), 7.36 (s, 1H), 4.32 (s, 2H). 13C NMR (151 MHz, CDCl3) d 164.43, 156.60, 152.07, 126.53, 126.27, 124.52, 121.52, 121.43, 42.11. MS (ESI): m/z = 227.0030 [M+H]+. FTIR (KBr, cm−1) 3506.54 (nNH secondary amine), 3381.16 (nNH acylamino), 2920.18 (nCH methylene), 2864.25 (nasCH methylene), 1693.48 (nC=O carbonyl), 1597.04 (nC=N thiazole), 1562.32 (nasC-C benzene), 1176.56 (nCH benzene), 773.44 (nCCl).

2 Experimental details

The carbon-bound hydrogen atoms were placed in their geometrically idealized positions and constrained to ride on their parent atoms.

3 Comment

Benzothaizole (BTA) is a fused benzoheterocyle which is present in many naturally occurring products and is responsible for the medicinal, pharmacological and pharmaceutical applications of such natural products. 4 Benzothiazole is a heterocyclic organic compound with a wide range of biological activities. 5 9

The basic structure of the title compound is a benzothiazole. The key lengths and angles obtained from the title structure are within the normal range and are consistent with those previously reported in similar structures. 10 , 11 The compound is prepared by the reaction of 2-aminobenzothiazole with chloroacetyl chloride. The crystal structure proves that the compound has been successfully acylated, and the bond length of the C=O bond is 1.221(6) Å. The benzothiazole ring and the phenyl ring have a dihedral angle of 0.18°. The nitrogen atom of the amide bond and the oxygen atom of the water form the intermolecular hydrogen bonds (see the figure).


Corresponding author: Yi-Xia Gong, College of Pharmacy, Jiamusi University, Jiamusi, 154007, P.R. China, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Excellent youth project of Heilongjiang Natural Science Foundation (YQ2021H027), and the project of Cultivating Young Innovative Talents in Heilongjiang Province (UNPYSCT-2020056), and National Fund Cultivation Program of Jiamusi University (JMSUGPZR2022-007).

  3. Competing interests: The authors declare no conflicts of interest regarding this article.

References

1. Sheldrick, G. M. SHELXTL – Integrated Space-Group and Crystal-Structure Determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Search in Google Scholar PubMed PubMed Central

2. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. OLEX2: a Complete Structure Solution, Refinement and Analysis Program. J. Appl. Cryst. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar

3. Sheldrick, G. M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

4. Keri, R. S.; Patil, M. R.; Patil, S. A.; Budagumpi, S. A Comprehensive Review in Current Developments of Benzothiazole-Based Molecules in Medicinal Chemistry. Eur. J. Med. Chem. 2015, 89, 207–251; https://doi.org/10.1016/j.ejmech.2014.10.059.Search in Google Scholar PubMed

5. Haroun, M.; Tratrat, C.; Petrou, A.; Geronikaki, A.; Ivanov, M.; Ćirić’, A.; Soković’, M.; Nagaraja, S.; Venugopala, K. N.; Balachandran Nair, A.; Elsewedy, H. S.; Kochkar, H. Exploration of the Antimicrobial Effects of Benzothiazolylthiazolidin-4-One and In Silico Mechanistic Investigation. Molecules 2021, 26, 4061; https://doi.org/10.3390/molecules26134061.Search in Google Scholar PubMed PubMed Central

6. Kumar, G.; Singh, N. P. Synthesis, Anti-inflammatory and Analgesic Evaluation of Thiazole/oxazole Substituted Benzothiazole Derivatives. Bioorg. Chem. 2021, 107, 104608; https://doi.org/10.1016/j.bioorg.2020.104608.Search in Google Scholar PubMed

7. Osmaniye, D.; Levent, S.; Karaduman, A. B. K.; Ilgin, S.; Özkay, Y.; Kaplancikli, Z. A. Synthesis of New Benzothiazole Acylhydrazones as Anticancer Agents. Molecules 2018, 23, 1054; https://doi.org/10.3390/molecules23051054.Search in Google Scholar PubMed PubMed Central

8. Khyati, B.; Sarkar, S. Benzothiazole Moiety and its Derivatives as Antiviral Agents. Med. Sci. Forum 2021, 7, 2–7.Search in Google Scholar

9. Nath, R.; Shahar, Y. M.; Pathania, S.; Grover, G.; Debnath, B.; Akhtar, M. J. Synthesis and Anticonvulsant Evaluation of Indoline Derivatives of Functionalized Aryloxadiazole Amine and Benzothiazole Acetamide. J. Mol. Struct. 2021, 1228, 129742; https://doi.org/10.1016/j.molstruc.2020.129742.Search in Google Scholar

10. Zhao, W. Crystal Structure of 3-(benzo[d]thiazol-2-Yl)-5-Bromo-2-Hydroxybenzaldehyde, C14H8BrNO2S. Z. Kristallogr. N. Cryst. Struct. 2024, 239, 281–283; https://doi.org/10.1515/ncrs-2023-0527.Search in Google Scholar

11. van Niekerk, X.; Gerber, T. I. A.; Hosten, E. C. Monodentate N/S-Donor Benzothiazole and Benzimidazole Coordination to the [Re(CO)3]+ Core. Polyhedron 2021, 203, 115171; https://doi.org/10.1016/j.poly.2021.115171.Search in Google Scholar

Received: 2024-03-08
Accepted: 2024-04-16
Published Online: 2024-04-30
Published in Print: 2024-08-27

© 2024 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of hexaquazinc(II) poly[hexakis(μ2-4-methylbenzenesulfinato-κ2O:O′) dizinc(II)]
  4. The crystal structure of poly[((2-(4,5-dihydro-1H-pyrazol-4-yl)-1,3-dioxoisoindoline-5-carbonyl)oxy)(1-(dimethylamino)ethoxy)zinc[II]], C16H14ZnN4O5
  5. Crystal structure of bis[(triaqua-4-iodopyridine-2,6-dicarboxylato-κ 3 N,O,O )cobalt(II)] trihydrate, C14H22N2O17I2Co2
  6. Crystal structure of bis(methanol-κO)-bis(nitrato-kO)-bis(1-((2-(2-chloro-4-(4-chlorophenoxy)phenyl)-4-methyl-1,3-dioxolan-2-yl)methyl)-1H-1,2,4-triazole-κN)cadmium(II), C40H42O14N8Cl4Cd
  7. Crystal structure of poly[μ2-dichlorido-(μ2-1-[(2,4-dimethyl-1H-triazole-1-yl)methyl]-1H-benzotriazole-κ2N:N′)cadmium(II)], C11H12CdN6Cl2
  8. The crystal structure of (3aS, 4R, 7S, 7aR)-hexahydro-4, 7-methano-1H-isoindole-1, 3-(2H)-dione, C9H11NO2
  9. The crystal structure of N-(acridin-9-yl)-4-chloro-N-(4-chloro-butanoyl) butanamide, C21H20Cl2N2O2
  10. Crystal structure of 3,3′-dimethoxy-4,4′-oxy-di-benzaldehyde, C16H14O5
  11. The crystal structure of tetrakis(μ 2-2-amino-3,5-dibromobenzoate-κ 2 O:O′)-octakis(n-butyl-κ 1 C)-bis(μ 3-oxo)tetratin(II), C60H92Br8N4O10Sn4
  12. Crystal structure of methyl-1-(naphthalen-1-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b] indole-3-carboxylate, C23H20N2O2
  13. Crystal structure of tetrapropylammonium bicarbonate–1-(diaminomethylene)thiourea(1/1)
  14. Crystal structure of 6,6′-((1E,1′E)-((2-phenylpyrimidine-4,6-diyl)bis(hydrazin-2-yl-1-ylidene))bis(methaneylylidene))bis(2-methoxyphenol)monohydrate, C26H26N6O5
  15. Crystal structure of bis(N,N,N-trimethylbutanaminium) tetrathiotungstate(VI), (BuMe3N)2[WS4]
  16. The crystal structure of 2,3,9-triphenyl-9-(2-phenylbenzofuran-3-yl)-9H-9λ 5-benzo[4,5][1,2]oxaphospholo[2,3-b][1,2,5]oxadiphosphole 2-oxide, C40H28O4P2
  17. Crystal structure of 1–methyl-3-propyl-4-nitro-1H-pyrazole-5-carboxylic acid, C8H11N3O4
  18. Crystal structure of N-(benzo[d]thiazol-2-yl)-2-chloroacetamide, C9H7ClN2OS
  19. The crystal structure of N-benzyl-2-chloro-N-(p-tolyl) acetamide, C16H16ClNO
  20. Crystal structure of 3,4-dimethoxybenzyl 2-(6-methoxynaphthalen-2-yl)propanoate, C23H24O5
  21. Crystal structure of 2,5-bis(2,5-dimethoxybenzyl)-3,6-dimethyl-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione, C26H28N2O6
  22. Crystal structure of poly[(μ3-5-bromoisophthalato-κ4 O,O′ :O″,O‴)-(μ2-1,2-bis(1,2,4-triazole-1-ylmethyl)benzene-κ2 N:N′)cobalt(II)], C20H15BrCoN6O4
  23. The crystal structure of bis(2-(piperidin-1-ium-4-yl)-1Hbenzo[d]imidazol-3-ium) dihydrogen decavanadate, C24H36N6O28V10
  24. Crystal structure of diaqua-bis(1-(3-carboxyphenyl)-5-methyl-4-oxo-1,4-dihydropyridazine3-carboxylato-O,O′)-cobalt(ii)dihydrate, C26H36N4O14Co
  25. Crystal structure of poly[(μ2-5-bromoisophthalato-κ4 O,O :O ,O )-(μ2-1,4-bis(2-methylimidazol-1-ylmethyl)benzene-N:N)cadmium(II)], C24H21BrCdN4O4
  26. The crystal structure of dimethyl 8-(3-methoxy-2-(methoxycarbonyl)-3-oxoprop-1-en-1-yl)-4-methyl-1-(p-tolyl)-1,3a,4,8b-tetrahydro-3H-furo[3,4-b]indole-3,3-dicarboxylate. C28H29NO9
  27. Crystal structure of (3R)-1-(3,5-dimethoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate chloride, C21H23ClN2O4
  28. Synthesis and crystal structure of 3-(4,5-dihydroisoxazol-3-yl)-2-methyl-4-(methylsulfonyl)benzoic acid, C12H13NO5S
  29. The crystal structure of hexaaquamagnesium(II) bis-3-(1,2,3,4-tetrahydrobenzo[4,5]imidazo[1,2-α]pyridin-1-yl)benzoate, C36H42N4O10Mg
  30. Crystal structure of 4-formyl-2-methoxyphenyl 2-acetoxybenzoate, C17H14O6
  31. Crystal structure of poly[octakis(μ-oxido)-tris(μ-1,1′-[[1,1′-biphenyl]-4,4′-diylbis(methylene)]bis(1H-imidazole))-tetrakis(oxido)-tetra-vanadium-dimanganese(II)dihydrate], C30H29MnN6O7V2
  32. Crystal structure of 4,8a-bis(4-chlorophenyl)-1,5,6-tris(4-fluorobenzyl)-1,4,4a,4b,5,6,8a,8b-octahydrocyclobuta[1,2-b:3,4-c′]dipyridine-3,8-dicarbonitrile, C45H33Cl2F3N4
  33. Crystal structure of benzo[d][1,3]dioxol-5-ylmethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C22H20O5
  34. Crystal structure of N-benzoyl-N-phenylhydroxylaminato-dicarbonylrhodium(I), [Rh(BNA)CO2]
  35. The crystal structure of N-(2-((2-methoxynaphthalen-1-yl)ethynyl)phenyl)-4-methylbenzenesulfonamide, C26H21NO3S
  36. The crystal structure of methyl ((4-aminobenzyl)sulfonyl)-d-prolinate, C13H18N2O4S
  37. The crystal structure of dichlorido-(N-isopropyl-N-(pyridin-2-ylmethyl)propan-2-amine-κ 2 N, N′)palladium(II), C12H20N2PdCl2
  38. Crystal structure of poly[(μ 2-5-hydroxyisophthalato-κ4 O,O′:O″,O‴)-(μ 2-1,4-bis(2-methylimidazolyl)-1-butene-N:N′)nickel(II)], C20H20NiN4O5
  39. The crystal structure of {hexakis(1-methyl-1H-imidazole-κ 1 N)cobalt(II)}(μ 2-oxido)-hexaoxido-dimolybdenum(VI)— 1-methyl-1H-imidazole (1/2), C32H48CoMo2N16O7
  40. Synthesis, crystal structure and nonlinear optical property of 1-((propan-2-ylideneamino)oxy)propan-2-yl-4-methylbenzenesulfonate, C13H19O4NS
  41. The crystal structure of N,N-(ethane-1,1-diyl)dibenzamide, C16H16N2O2
  42. Crystal structure of 1-(4-bromophenyl)-3-(diphenylphosphoryl)-3-hydroxypropan-1-one, C21H18BrO3P
  43. The crystal structure of fac-tricarbonyl(bis(3,5-dimethyl-4H-pyrazole)-κ1 N)-((nitrato)-κ1 O)-rhenium(I)— 3,5-dimethyl-4H-pyrazole(1/1), C18H23N7O6Re
  44. The crystal structure of 4′-chloro-griseofulvin: (2S,6′R)-4′,7-dichloro-4,6-dimethoxy-6′-methyl-3H-spiro[benzofuran-2,1′-cyclohexan]-3′-ene-2′,3-dione, C16H14Cl2O5
  45. Crystal structure of tetraethylammonium bicarbonate–1-(diaminomethylene)thiourea(1/1)
  46. Crystal structure of 1-cyclohexyl-4-p-tolyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester, C22H27NO4
  47. The crystal structure of catena-poly(μ2-1,4-bis-(1H-imidazol-1-yl)benzene-copper(I)) dichloridocopper(I), {[CuC12H10N4]+[CuCl2]} n
  48. The crystal structure of propane-1-aminium-2-carbamate, C4H10N2O2
  49. Crystal structure of 5,6,3′,4′,5′-pentamethoxy-flavone dihydrate, C20H24O9
  50. Crystal structure of (E)-N-(2-bromophenyl)-4-(4-(3,5-dimethoxystyryl)phenoxy)pyrimidin-2-amine, C26H22BrN3O3
  51. Crystal structure of methyl (3R)-1-(2-bromo-4-fluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride hydrate, C19H19BrClFN2O3
  52. The crystal structure of 1-(2-chlorophenyl)-3-(p-tolyl)urea, C14H13ClN2O
  53. The crystal structure of 1-cyclohexyl-3-(p-tolyl)urea, C14H20N2O
  54. Crystal structure of ((benzyl(hydroxy)-amino)(4-chlorophenyl)methyl)-diphenylphosphine oxide, C26H23ClNO2P
  55. The crystal structure of ethyl 3-(1-methyl-1H-indole-2-carbonyl)-2-phenylquinoline-4-carboxylate, C28H22N2O3
  56. The crystal structure of 1,4-bis(1H-imidazol-3-ium-1-yl)benzene dinitrate, C12H12N4 2+·2(NO3 )
  57. Crystal structure of tris(hexafluoroacetylacetonato-κ2O,O′) bis(triphenylphosphine oxide-κ1O)samarium(III), C51H33F18O8P2Sm
  58. Crystal structure of 1-(4-(dimethylamino)phenyl)-2,3-bis(diphenylphosphoryl)propan-1-one, C35H33NO3P2
  59. Crystal structure of diaqua[bis(μ 2-pyridine 2,6-dicarboxylato) bismuth(III) potassium(I)], C14H10BiKN2O10
  60. Crystal structure of (R)-N, N -dimethyl-[1, 1′-binaphthalene]-2, 2′-diamine, C22H20N2
  61. Crystal structure of 1-phenyl-4-(2-furoyl)-3-furyl-1H-pyrazol-5-ol, C18H12N2O4
  62. Crystal structure of bis(14,34-dimethyl[11,21:23,31-terphenyl]-22-yl)diselane, C40H34Se2
Downloaded on 22.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2024-0116/html
Scroll to top button